HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antonino Belfiore Selected Research
Antonino Belfiore Research Topics
Disease
69
Neoplasms (Cancer)
10/2022 - 01/2002
27
Breast Neoplasms (Breast Cancer)
07/2022 - 06/2004
12
Neoplasm Metastasis (Metastasis)
10/2022 - 08/2004
9
Thyroid Neoplasms (Thyroid Cancer)
05/2020 - 01/2002
9
Prostatic Neoplasms (Prostate Cancer)
12/2017 - 03/2005
6
Inflammation (Inflammations)
10/2021 - 09/2012
6
Urinary Bladder Neoplasms (Bladder Cancer)
11/2020 - 01/2012
5
Papillary Thyroid Cancer
10/2022 - 07/2003
5
Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 11/2017
5
Carcinogenesis
11/2020 - 01/2012
5
Insulin Resistance
01/2017 - 10/2009
4
Obesity
01/2022 - 08/2011
4
Hyperinsulinism (Hyperinsulinemia)
01/2022 - 10/2009
4
Type 2 Diabetes Mellitus (MODY)
08/2021 - 10/2009
4
Carcinoma (Carcinomatosis)
01/2017 - 07/2003
3
Triple Negative Breast Neoplasms
06/2022 - 11/2021
3
Lung Neoplasms (Lung Cancer)
01/2022 - 03/2009
3
Graves Ophthalmopathy
03/2021 - 01/2020
3
Hypoxia (Hypoxemia)
08/2020 - 01/2013
3
Mesothelioma
11/2019 - 08/2016
2
Hyperthyroidism
03/2021 - 01/2020
2
Graves Disease (Basedow Disease)
03/2021 - 06/2004
2
Lymphatic Metastasis
01/2019 - 08/2004
2
Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2016
2
Leiomyosarcoma
10/2014 - 11/2002
2
Non-alcoholic Fatty Liver Disease
11/2013 - 01/2012
2
Ewing Sarcoma (Sarcoma, Ewing)
01/2013 - 09/2012
2
Sarcoma (Soft Tissue Sarcoma)
01/2013 - 01/2013
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022
1
Disease Progression
10/2022
1
Adenoma (Adenomas)
03/2022
Drug/Important Bio-Agent (IBA)
27
Insulin (Novolin)
FDA Link
01/2022 - 11/2002
23
Insulin Receptor
IBA
01/2022 - 01/2002
19
Protein Isoforms (Isoforms)
IBA
11/2021 - 01/2002
17
Biological Products
IBA
01/2022 - 11/2002
17
Insulin-Like Growth Factor II (Somatomedin A)
IBA
01/2018 - 01/2002
16
Insulin-Like Growth Factor I (IGF-1)
IBA
02/2021 - 03/2005
16
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
01/2017 - 11/2002
12
Estrogen Receptors
IBA
01/2022 - 09/2007
10
Estrogens (Estrogen)
FDA Link
11/2021 - 09/2007
9
Ligands
IBA
11/2020 - 08/2011
8
Biomarkers (Surrogate Marker)
IBA
07/2022 - 01/2012
8
Metformin (Glucophage)
FDA Link
Generic
01/2022 - 01/2012
7
Insulin-Like Peptides
IBA
01/2022 - 09/2007
7
Somatomedin Receptors (Somatomedin Receptor)
IBA
01/2021 - 09/2007
7
Progranulins
IBA
11/2020 - 01/2015
7
GTP-Binding Proteins (G-Protein)
IBA
08/2020 - 10/2014
7
Proteins (Proteins, Gene)
FDA Link
08/2020 - 06/2003
7
Androgens
IBA
12/2017 - 03/2005
6
Pharmaceutical Preparations
IBA
01/2022 - 01/2013
6
Collagen Receptors
IBA
01/2021 - 06/2015
5
Discoidin Domain Receptor 1
IBA
01/2021 - 06/2015
5
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2020 - 01/2015
4
MicroRNAs (MicroRNA)
IBA
03/2022 - 01/2017
4
Androgen Receptors (Androgen Receptor)
IBA
04/2014 - 03/2005
3
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 03/2009
3
Antineoplastic Agents (Antineoplastics)
IBA
01/2022 - 01/2017
3
Integrins
IBA
01/2019 - 01/2017
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2018 - 04/2014
3
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2013 - 08/2011
2
Cytokines
IBA
11/2021 - 08/2020
2
Glucagon-Like Peptide 1 (GLP 1)
IBA
08/2021 - 11/2013
2
Cisplatin (Platino)
FDA Link
Generic
11/2020 - 06/2016
2
Heavy Metals
IBA
05/2020 - 12/2017
2
Metals
IBA
05/2020 - 12/2017
2
Capecitabine (Xeloda)
FDA Link
03/2020 - 01/2020
2
Bevacizumab (Avastin)
FDA Link
01/2020 - 01/2019
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020 - 01/2020
2
Enzymes
IBA
01/2019 - 07/2003
2
Collagen
IBA
01/2018 - 01/2017
2
Copper
IBA
12/2017 - 10/2015
2
Zinc
IBA
12/2017 - 01/2017
2
Trace Elements (Biometals)
IBA
12/2017 - 01/2017
2
sortilin
IBA
12/2017 - 01/2015
2
Catenins
IBA
11/2017 - 01/2017
2
Thiazolidinediones
IBA
01/2017 - 11/2013
2
Therapeutic Uses
IBA
06/2016 - 01/2013
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2016 - 06/2015
2
Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)
IBA
04/2014 - 09/2009
2
Antibodies
IBA
09/2012 - 07/2003
2
Complementary DNA (cDNA)
IBA
05/2012 - 10/2002
2
Steroids
IBA
09/2009 - 02/2009
1
cabozantinib
IBA
10/2022
1
lenvatinib
IBA
10/2022
1
Trastuzumab (Herceptin)
FDA Link
07/2022
1
human ERBB2 protein
IBA
07/2022
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
06/2022
1
Filamins
IBA
06/2022
1
Carbohydrates
IBA
01/2022
1
Progesterone Receptors (Progesterone Receptor)
IBA
01/2022
Therapy/Procedure
30
Therapeutics
10/2022 - 11/2002
4
Drug Therapy (Chemotherapy)
01/2022 - 01/2013
3
Glycemic Control
08/2021 - 11/2013
2
Thyroidectomy
10/2022 - 01/2019
2
Immunotherapy
01/2022 - 01/2022
2
Mediterranean Diet
10/2021 - 01/2019
2
Castration
12/2017 - 01/2015
1
Radiotherapy
10/2022
1
Lymph Node Excision (Lymph Node Dissection)
10/2022
1
Protein-Restricted Diet (Diet, Protein Restricted)
01/2022